Fate Therapeutics, Inc. short interest in 2024
In 2024, Fate Therapeutics, Inc.'s disclosed short interest ran from 10.92% of shares outstanding on 12 Jan 2024 to 9.83% on 31 Dec 2024, a change of -1.09 percentage points. The year's high was 22.45% on 30 Apr 2024 and its low 9.12% on 15 Nov 2024, averaging 14.34% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.39 days on 13 Sep 2024. Full history: Fate Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 10.92% (12 Jan 2024)
- End of year
- 9.83% (31 Dec 2024)
- Change
- -1.09 pp
- High
- 22.45% (30 Apr 2024)
- Low
- 9.12% (15 Nov 2024)
- Average
- 14.34%
- Highest days to cover
- 16.39 (13 Sep 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 10.92% | 4.11 | |
| 31 Jan 2024 | 11.64% | 3.33 | |
| 15 Feb 2024 | 13.50% | 4.16 | |
| 29 Feb 2024 | 13.68% | 5.41 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 13.34% | 4.44 | |
| 28 Mar 2024 | 16.72% | 6.70 | |
| 15 Apr 2024 | 19.19% | 9.89 | |
| 30 Apr 2024 | 22.45% | 7.94 | |
| 15 May 2024 | 18.28% | 6.65 | 10-Q filed, results (8-K) |
| 31 May 2024 | 19.62% | 11.32 | |
| 14 Jun 2024 | 18.58% | 11.68 | |
| 28 Jun 2024 | 17.46% | 7.19 | |
| 15 Jul 2024 | 17.82% | 14.81 | |
| 31 Jul 2024 | 12.12% | 5.31 | |
| 15 Aug 2024 | 12.24% | 7.35 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 13.32% | 11.29 | |
| 13 Sep 2024 | 13.21% | 16.39 | |
| 30 Sep 2024 | 12.45% | 13.30 | |
| 15 Oct 2024 | 14.11% | 13.88 | |
| 31 Oct 2024 | 13.96% | 12.26 | |
| 15 Nov 2024 | 9.12% | 6.42 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 9.96% | 1.66 | |
| 13 Dec 2024 | 10.70% | 3.72 | |
| 31 Dec 2024 | 9.83% | 3.14 |
See also: Fate Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.